Between the classic hit and the modern sequel: transition dosing between peginterferon alfa-2a and ropeginterferon alfa-2b for myeloproliferative neoplasms.

Authors

Ghaith Abu-Zeinah, Gabriela Hobbs, Brandi N Reeves, Abdulraheem Yacoub, Joseph M Scandura

Published in

Annals of hematology. Volume 105. Issue 7. Jun 24, 2026. Epub Jun 24, 2026.

PMID:
42340451
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.